ADTX
Aditxt Inc
NASDAQ · Biotechnology
$0.65
+0.03 (+4.55%)
Open$0.62
Previous Close$0.62
Day High$0.73
Day Low$0.58
52W High$15.56
52W Low$9.74
Volume—
Avg Volume152.6K
Market Cap364.2K
P/E Ratio16.84
EPS$0.73
SectorBiotechnology
Analyst Ratings
Strong Buy
8 analysts
Price Target
+1,973.7% upside
Current
$0.65
$0.65
Target
$13.50
$13.50
$9.80
$13.50 avg
$19.20
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 181.3K | 180.5K | 146.0K |
| Net Income | -17,696 | -19,611 | -15,138 |
| Profit Margin | -9.8% | -10.9% | -10.4% |
| EBITDA | -22,705 | -25,362 | -18,933 |
| Free Cash Flow | -14,609 | -13,693 | -9,143 |
| Rev Growth | -0.2% | +10.1% | +10.9% |
| Debt/Equity | 1.30 | 0.93 | 1.16 |
Dividend
Dividend Yield2.02%
Annual Dividend$0.25
Payout Ratio34.1%
Frequencymonthly
Ex-DividendFeb 15, 2026
Pay DateMar 7, 2026
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |